HY-W181102-100mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
HY-W181102-50mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
HY-W181102-1mL
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0537B-100mg
|
MedChemexpress LLC
|
Pentamidine (isethionate) [CAS 140-64-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0537B-50mg
|
MedChemexpress LLC
|
Pentamidine (isethionate) [CAS 140-64-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0537B-1mL
|
MedChemexpress LLC
|
Pentamidine (isethionate) [CAS 140-64-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-W004520-1g
|
MedChemexpress LLC
|
Phenazine (methylsulfate) [CAS 299-11-6]
|
|
COVID-19-immunoregulation
|
|
HY-W004520-100mg
|
MedChemexpress LLC
|
Phenazine (methylsulfate) [CAS 299-11-6]
|
|
COVID-19-immunoregulation
|
|
HY-W004520-5g
|
MedChemexpress LLC
|
Phenazine (methylsulfate) [CAS 299-11-6]
|
|
COVID-19-immunoregulation
|
|
HY-W004520-500mg
|
MedChemexpress LLC
|
Phenazine (methylsulfate) [CAS 299-11-6]
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-10mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-25mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-5mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-50mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mL
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-124756-1mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-10mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-100mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-25mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-5mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-50mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-1mL
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-13756A-10mg
|
MedChemexpress LLC
|
TacroliMu s (monohydrate) [CAS 109581-93-3]
|
|
COVID-19-immunoregulation
|
|
HY-13756A-5mg
|
MedChemexpress LLC
|
TacroliMu s (monohydrate) [CAS 109581-93-3]
|
|
COVID-19-immunoregulation
|
|